Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enamel Matrix Derivative for Infrabony Defects
NCT02195765Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2002
- Primary completion
- Oct 2004
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Randomised, double-blind trial of enamel matrix derivative in chronic periodontitis (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Distance from the cemento-enamel junction to the bottom of the defect at 24 months. Started Jun 2002; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02195765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195765.